Open AccessGLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS
Author(s) -
Т Е Шмидт
Publication year - 2016
Publication title -
nevrologiâ, nejropsihiatriâ, psihosomatika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.157
H-Index - 9
eISSN - 2310-1342
pISSN - 2074-2711
DOI - 10.14412/2074-2711-2016-4-77-80
Subject(s) - glatiramer acetate , multiple sclerosis , medicine , remyelination , drug , neuroprotection , pharmacology , neurotrophic factors , immunology , central nervous system , myelin , receptor